TANDEM DIABETES CARE H-1B Visa Sponsorship & Salary Data

The median H-1B salary at TANDEM DIABETES CARE is $139,045, based on 39 certified filings from FY 2020 to FY 2025. This is 16% higher than the national H-1B median salary of $120,000. Compensation at TANDEM DIABETES CARE reflects their market positioning, with entry-level roles starting around $120,000 and senior positions reaching $175,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at TANDEM DIABETES CARE range from $100,000 at the 10th percentile to $175,000 at the 90th percentile, showing a $75,000 spread across experience levels and roles. The 25th percentile is $120,000 and the 75th percentile is $155,000.

Yes, TANDEM DIABETES CARE actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), TANDEM DIABETES CARE filed 7 H-1B labor condition applications with 7 certified and 0 denied, at a median salary of $147,590. Across FY 2020–2025, they have filed 43 total H-1B applications with 39 certified and a 2.3% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. TANDEM DIABETES CARE sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), TANDEM DIABETES CARE filed 7 H-1B applications, with 7 certified and 0 denied. Over 6 years of data, TANDEM DIABETES CARE has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

TANDEM DIABETES CARE's LCA (Labor Condition Application) denial rate is 2.3%, with 1 out of 43 applications denied across all years. This translates to a 97.7% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating TANDEM DIABETES CARE as a potential H-1B sponsor.

This denial rate is higher than average. Applicants should ensure all documentation is thoroughly prepared and work closely with TANDEM DIABETES CARE's immigration team.

TANDEM DIABETES CARE sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 39 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles TANDEM DIABETES CARE most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at TANDEM DIABETES CARE:

The most frequently sponsored role is Senior Software Engineer with 8 filings at a median salary of $140,566. This is followed by Sr. Applications Developer II (6 filings) and Software Engineer II.

TANDEM DIABETES CARE's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where TANDEM DIABETES CARE sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top TANDEM DIABETES CARE H-1B locations:

The largest H-1B hub for TANDEM DIABETES CARE is San Diego, CA with 24 filings at a median salary of $135,000. The highest-paying location is Dublin, OH at $180,000 median. Salaries range from $100,000 to $180,000 across office locations.

TANDEM DIABETES CARE's median H-1B salary has increased by +25% from FY 2020 ($117,832) to FY 2025 ($147,590). Tracking salary trends over time reveals how TANDEM DIABETES CARE adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at TANDEM DIABETES CARE.

Year-by-year breakdown:

• FY 2021: $130,000 (5 certified)
• FY 2022: $140,000 (10 certified)
• FY 2023: $150,000 (8 certified)
• FY 2024: $135,000 (8 certified)
• FY 2025: $147,590 (7 certified)

This 25% growth reflects strong compensation adjustments at TANDEM DIABETES CARE, keeping pace with market demands for H-1B talent.

TANDEM DIABETES CARE primarily files H-1B applications at Wage Level IV, accounting for 48% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making TANDEM DIABETES CARE's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 97% of positions at Level II or higher, TANDEM DIABETES CARE typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

TANDEM DIABETES CARE's median H-1B salary of $139,045 is 16% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating TANDEM DIABETES CARE's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare TANDEM DIABETES CARE's offerings with similar companies in your field for a more accurate assessment.

TANDEM DIABETES CARE offers above-average H-1B compensation. Combined with their 39 certified filings and 2.3% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. TANDEM DIABETES CARE's higher proportion of Level III-IV positions (76%) may benefit from wage-based lottery prioritization.

With 39 certified filings, TANDEM DIABETES CARE invests significantly in H-1B sponsorship. The company's 2.3% denial rate suggests solid H-1B processing practices.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.